Advancing Bispecifics for Combination Immunotherapy
PharmaTalkRadio2 Mars 2020

Advancing Bispecifics for Combination Immunotherapy

First recorded at the fourth annual IO Combinations 360° conference, this panel moderated by Dr Daniel Chen, IGM Biosciences discusses advancing bispecifics for combination immunotherapy. This discussion covers the following topics: What are the types of bispecifics and what are the limitations?What are the toxicity related side effects?What are teh next steps/levels for bispecifics?What does the future hold for bispecifics? Panelists include: Julie Bailis, PhD, AmgenRajkumar Ganesan, PhD, Janssen Research & DevelopmentDavid Schaer, PhD, Pfizer To learn more about the 5th annual IO Combinations 360° conference please visit www.iocombinations360.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
medicinvetarna
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
rss-spraket
det-morka-psyket
rss-vetenskapsradion
sexet
halsorevolutionen
paranormalt-med-caroline-giertz
dumforklarat
rss-vetenskapsradion-2
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
vetenskapsradion
rss-ronden
4health-med-anna-sparre
rss-italiensk-dagbok